Personalized Medicine Market is Expected to Grow at a Robust CAGR of 12.01% by 2022

Personalized Medicine Market- Industry Outlook and Trend Analysis-
The personalized medicine industry comprehends custom-made medical products split into PM therapeutics, PM diagnostics, nutrition & wellness, and PM care. PM diagnostics and therapeutics cover direct-to-consumer diagnostics, genetic testing, esoteric lab tests and services, medical devices and pharmaceutical & genomic medicine. PM therapeutics and diagnostics sections are anticipated to grow at a significant rate over the next few years due to the increasing adoption of DNA/RNA screening for medical treatment and therapy and expansion of next-generation sequencing over the forecast years. Introduction and development of companion diagnostics and linked medicines are also projected to lead towards the global personalized medicine market growth. Nutritional wellness and medical care segments involve health information technology, telemedicine, retail nutrition, diseases management, alternative and complementary medicine. These reported for a considerably large section of the global market revenue in 2014 and are anticipated to maintain the leading market position till 2022, due to excessive usage rates, across the distribution and counter sale, growth, and development of retail clinics and growing complementary medicine adoption. Further integration and implementation of healthcare IT systems and telemedicine with hospital workflow frameworks and operation are also anticipated to boost the demand for the global personalized medicine market during the next few years. Although this industry has key application in oncology currently, it is anticipated that during the forecast years, the market will experience growth in applications section like CNS disorders, psychiatry, and cardiovascular & infectious diseases.

Regional Outlook and Trend Analysis- Personalized Medicine Market
In 2014, North American regional personalized medicine market ruled global demand, due to supportive NIH policies and government funding, rising adoption of clinical practitioners, central consolidation of healthcare IT and EHR systems with hospital operations, and incorporation into clinical trials. Technological advancements of next-generation sequencing ensuing in cost decline of genomic sequencing is too an elevated impact providing factor projected to bestow towards the growth of the market. Though, the Asia-Pacific regional personalized medicine industry is anticipated witness major gains during the forecasted years due to the existence of a considerably large base of unfulfilled industry demand, rising technological progression of the regional medical framework and rising awareness regarding genetic diagnostics, therapeutics, and genomic sequencing.

Competitive Insights- Personalized Medicine Market
Major market players are Quest Diagnostics, 3G Biotech, Laboratory Corporation of America, Agendia NV, Abbott, AsuragenInc, CardioDx Inc., Becton Dickinson & Co., Foundation Medicine Inc., Siemens Healthcare Diagnostics Inc., Qiagen Inc., Amgen Inc., GE Healthcare, Bristol-Myers Squibb, Pfizer Inc., 23andMe, Sanofi, Illumina Inc., Astra Zeneca PLC, Roche Holding AG, Vertex Pharmaceuticals Inc., American Association for Cancer Research and Merck & Co. Inc.

Browse Full Market Report and in-depth TOC on Personalized Medicine Market at: www.crystalmarketresearch.com/report/personalized-medicin...

Organization Outlook and Trend Analysis:
In 2012, the global personalized medicine market was evaluated around USD 806.97 billion and is expected to reach approximately USD 5208.68 billion by 2022 while registering itself at a compound annual growth rate (CAGR) of 12.01% over the forecast period.
Major driving factors of the global market are increasing development of whole genome, companion diagnostics, next-generation sequencing technology, and rising retail clinics. Rising healthcare spending levels stimulating the demand for an efficient cancer diagnostic procedure, rising incidence of cancer and growing utilization of amalgamation biomarkers for diagnostics are some factors projected to boost the growth of the global market. Rising implementation of next-generation sequencing by medical practitioners and clinicians for genetic mapping of patients worldwide and increasing support for the personalized drug by regulatory and reimbursement landscape are also expected driving factors for global demand over 2022.

The Personalized Medicine Market is segmented as follows-
Personalized Medicine (PM) Market, By Product, Estimates and Forecast, 2012-2022 ($Million)

PM Diagnostics
Genetic Testing
Direct-to-consumer Diagnostics
Esoteric Lab Services
Esoteric Lab Tests
PM Therapeutics
Pharmaceutical
Genomic Medicine
Medical Devices
Personalized Medical Care
Telemedicine
Healthcare Information Technology
Diseases Management
Personalized Nutrition & Wellness
Retail Nutrition
Complementary Medicine
Alternative Medicine

Get sample Copy of this Report: www.crystalmarketresearch.com/report-sample/HC11358

What makes our report unique?
1) An extensive research study on the Global Personalized Medicine market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the Personalized Medicine market.

2) We provide you the longest possible market segmentation based on type of products, procedures and geography and describe the market share region wise.

3) The report gives a bird eyes view on the competitive landscape which includes mergers and acquisitions, collaborations, market strategies, and new product launches.

Feel free to get in touch for discounts and customized details: www.crystalmarketresearch.com/check-discount/HC11358

Major List of Tables:
Table 1.Personalized Medicine (PM) Market, By Product ($Million), 2012-2022
Table 2.PM Diagnostics Market, By Region ($Million), 2012-2022
Table 3.Genetic Testing Market, By Region ($Million), 2012-2022
Table 4.Esoteric Lab Services Market, By Region ($Million), 2012-2022
Table 5.Esoteric Lab Tests Market, By Region ($Million), 2012-2022
Table 6.PM Therapeutics Market, By Region ($Million), 2012-2022
Table 7.Pharmaceutical Market, By Region ($Million), 2012-2022
Table 8.Genomic Medicine Market, By Region ($Million), 2012-2022
Table 9.Medical Devices Market, By Region ($Million), 2012-2022
Table 10.Personalized Medical Care Market, By Region ($Million), 2012-2022
Table 11.Telemedicine Market, By Region ($Million), 2012-2022
Table 12.Healthcare Information Technology Market, By Region ($Million), 2012-2022
Table 13.Diseases Management Market, By Region ($Million), 2012-2022
Table 14.Personalized Nutrition & Wellness Market, By Region ($Million), 2012-2022
Table 15.Retail Nutrition Market, By Region ($Million), 2012-2022
Table 16.Complementary Medicine Market, By Region ($Million), 2012-2022
Table 17.Alternative Medicine Market, By Region ($Million), 2012-2022
Table 18.North America Personalized Medicine (PM) Market, By Country, 2012-2022 ($Million)
Table 19.North America Personalized Medicine (PM) Market, By Product, 2012-2022 ($Million)

…CONTINUED FOR TOC

Enquire about Extensive Report at: www.crystalmarketresearch.com/send-an-enquiry/HC11358

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:
Crystal Market Research
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States